-
a large interdisciplinary team. Studies will be supported by the School of Science and Technology at Nottingham Trent University, the 2023 Modern University of the Year (Times Higher Education). The
-
of new therapies. In this PhD studentship, we propose to apply a technology recently patented by our lab that allows upscaling the manufacture of 3D human muscle models, in vitro. Upscaling the manufacture
-
Technology on our Clifton Campus. For more details, please take a look at the role profile. We'll still consider applications even if you don't meet every single one of the requirements, so don't be put off
-
creative philosophies. For any informal queries about the role or the ADBE team, please contact Professor Amin Al-Habaibeh (Professor of Intelligent Engineering Systems ) at [email protected].
-
About the Role HOURLY PAID LECTURERS – rETRO-FIT tECHNOLOGIES Special conditions: £48.53 per direct teaching hour. This includes the following elements: delivery, preparation and assessment of the scheduled programme of work. (Flat rate of £19.42 per hour will be paid for completing one of the...
-
mutant in C. hiranonis using RiboCas. The PhD’s goal is to capitalize on these breakthroughs and use engineering biology to create microbes that can modulate the composition of bile acids in the gut as a
-
About the Role Our Costume Design & Construction BA (Hons) course sits within the Design for Performance subject area, which is part of the Design & Digital Arts Department within the Nottingham School of Art and Design. The course benefits from an excellent reputation and recruit’s high calibre...
-
energy systems, this project will us use artificial intelligence and data sciences methods (like technology feasibility modelling), to simulate and assess the energy needs of local homes. The research will
-
Environmental Sciences Biosciences Chemistry Sport Science Mathematics Physics Engineering At the University of Nottingham: Biosciences Chemistry Engineering Life Sciences Mathematical Sciences Medicine Pharmacy
-
biotechnology company headquartered in St. Louis, USA, who is leveraging its proprietary Moneta™ platform and deep genomic engineering expertise to pioneer a new class of memory NK cell therapies to treat